Sherif BN, Sherrill B, Amonkar M, Wu Y, Maltzman J, O'Rourke L, Johnston S. Lapatinib plus letrozole compared with letrozole alone as first-line therapy in hormone receptor positive her2+ metastatic breast cancer: a quality of life analysis. Poster presented at the 2009 ASCO Annual Meeting; June 2, 2009.